Pathogenesis of Spongiform Encephalopathies: An Update

International Archives of Allergy and Immunology

Volumn 110, Issue 2, 1996, Pages 99-106

  Adriano, Aguzzi ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; Fatal familial; Gerstmann Strandauml; ussler Scheinker; Insomnia; Knockout mice; Prions; PrP proteins; Syndrome; Transgenic mice

Indexed keywords

BRAIN SPONGIOSIS; CATTLE DISEASE; CENTRAL NERVOUS SYSTEM; HUMAN; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRION; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

EID: 0029914645     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237273     Document Type: Article

References (67)

1. Cuille J. Chelle PI.: Experimental transmission of trembling to the goat. C R Seances Acad Sci 1939;208:1058-1160.
2. Gordon WS: Advances in Veterinary Research. Vet Rec 1946:58:516.
3. Prusiner SB: Novel proteinaceous infectious particles cause scrapie. Science 1982:216:136-144.
4. Hadlow WJ: Scrapie and kuru. Lancet 1959;2: 289-290.
5. Beck E. Daniel IM. Alpers M, Gajdusek DC, Gibbs CJ: Experimental ‘kuru’ in chimpanzees. A pathological report. Lancet I966;2:l056-1059.
6. Gajdusek DC. Gibbs CJ. Alpers M: Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 1966;209:794-796.
7. Gibbs CJ Jr. Gajdusek DC. Asher DM. Alpers MP, Beck E. Daniel PM, Matthews WB: Crcutzfeldt-Jakob disease (spongiform encephalopathy): Transmission to the chimpanzee. Science 1968; 161:388-389.
8. Collinge J, Palmer MS, Sidle KCL, Gowland I, Medori R, Ironside JW, Lantos PL: Transmission of fatal familial insomnia to laboratory animals. Lancet 1995:346:569-570.
9. Talcishi J. Brown P, Kitamoto T, lloque MZ. Roos R. Wollman R. Cervenakova L. Gajdusek DC: First experimental transmission of fatal familiar insomnia. Nature 1995:376:434-435.
10. Wells GA. Scott AC, Johnson CT, Gunning RE. Ilancock RD. Jeffrey M. Dawson M. Bradley R: A novel progressive spongiform encephalopathy in cattle' Vet Rec 1987:121:419-420.
11. Wilcsmith JW, Hoinville LJ, Ryan JB, Sayers AR, Bovine spongiform encephalopathy: Aspects of the clinical picture and analyses of possible changes 1986-1990. Vet Rec 1992:130: 197-201.
12. Baslcr K. Oesch B. Scott M. Westaway D, Wal-ehli M, Groth DF, Mc Kinley MP, Prusiner SB, Weissmann C: Scrapie and cellular PrP iso-forms are encoded by the same chromosomal gene. Cell 1986:46:417-428.
13. Oesch B, Westaway D. Walchli M, Mc Kinley MP. Kent SB. Acbcrsold R. Barry RA. Tempst P. Teplow DB, Hood LE. et al: A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985:40: 735-746.
14. Stahl N, Borchelt DR, Hsiao K, Prusiner SB: Scrapie prion protein contains a phosphatidyl-inositol glycolipid. Cell 1987 51:229-240.
15. Baldwin MA, Stahl N, Reinders LG. Gibson BW, Prusiner SB. Burlingame AL: Pcrmethyla-lion and tandem mass spectrometry of oligosaccharides having free hexosaminc: Analysis of the glycoinositol phospholipid anchor glycan from the scrapie prion protein. Anal Biochcm 1990:191:174 182.
16. Brown HR, Goller N. L, Rudelli R. D, Merz G. S, Wolfe G. C, Wisniewski H. M, Robakis NK: The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells. Acta Neuropathol (Berl) 1990;80:1-6.
17. Moser M, Colello R. I, Pott U, Oesch B: Developmental expression of the prion protein gene in glial cells. Neuron 1995; 14:509-517.
18. Kitamoto T, Muramoto T, Mohri S, Dohura K, Tatcishi J: Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Crcutzfcldt-Jakob disease. J Virol 1991; 65:6292-6295.
19. Muramoto T, Kitamoto T. Hoque MZ. Tateishi J, Goto I: Species barrier prevents an abnormal isoform of prion protein from accumulating in follicular dendritic cells of mice with Creutz-leldt-Jakob disease. J Virol 1993:67:6808-6810.
20. Kocisko DA, Come J. H, Priola S. A. C'hesebro 13. Raymond GJ. Lansbury PT. C'aughey 13: Cell-free formation of protcase-rcsistant prion protein. Nature 1994;370:471-474.
21. Kocisko DA. Priola SA. Raymond GJ, Chcse-bro B, Lansbury PT Jr. Caughey B: Species specificity in the ccll-frce conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier. Proc Natl Acad Sci USA 1995;92:3923-3927.
22. Taraboulos A. Serban D. Pmsiner SB: Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol 1990:110:2117-2132.
23. Mc Kinley MP. Taraboulos A. Kenaga L, Serban D. Stieber A, DeArmond SJ, Prusiner SB. Go-natas N: Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest 1991:65:622-630.
24. Kellings K, Meyer N, Mirenda C, Prusiner S. B, Riesner D. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J Gen Virol 1992;73:1025-1029.
25. Meyer N. Rosenbaum V, Schmidt B, Gilles K. Mirenda C. Groth D. Prusiner SB. Riesner D. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol 1991;72:37-49.
26. Brown P, Liberski P. P, Wolff A, Gajdusek D. C: Resistance of scrapie infectivity to steam auto-claving after formaldehyde fixation and limited survival after ashing at 360 degrees C: Practical and theoretical implications. J Infect Dis 1990; 161:467-472.
27. Wcstaway D, Goodman PA, Mirenda C. A, Mc Kinley M. P, Carlson G. A, Prusiner S. B: Distinct prion proteins in short and long scrapie incubation period mice. Cell 1987:51:651-662.
28. Carlson GA. Westaway D. Goodman PA. Peterson M. Marshall ST. Prusiner SB: Genetic control of prion incubation period in mice. Ciba Found Symp 1988;135:84-99.
29. Lowenstein DU. Butler DA. Wcstaway D. Mc Kinley MP. DeArmond SJ. Prusiner SB: Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins. Mol Cell Biol 1990:10:1153-1163.
30. Hunter N. Foster JD. Dickinson AG. Hope J: Linkage of the gene for the scrapie-associated fibril protein (PrP) to the Sip gene in Cheviot sheep. Vet Rec 1989:124:364-366.
31. Westaway D. Mirenda CA. Foster D. Zcbarja-dian Y. Scott M. Torchia M. Yang SL. Serban H, DeArmond S. J, Fbeling C, et al: Paradoxical shortening of scrapie incubation times by expression of prion protein transgenes derived from long incubation period mice. Neuron 1991:7:59-68.
32. Hsiao K, Baker H. F, Crow T. J, Poulter M, Owen F, Terwilliger J. D, Wcstaway D, Ott J, Prusiner SB: Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 1989:338:342-345.
33. Collinge J, Harding AE, Owen F. Poulter M. Lofthouse R. Boughey AM. Shah T, Crow TJ: Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis. Lancet 1989;2: 15-17.
34. Doh ura K. Tateishi J. Sasaki H. Kitamoto T. Sa-kaki Y: Proleu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome. Biochcm Biophys Res Commun 1989: 163:974-979.
35. Owen F. Poulter M. Collinge J. Leach M. Lofthouse R. Crow TJ. Harding AE: A dementing illness associated with a novel insertion in the prion protein gene. Brain Res Mol Brain Res 1992:13:155-157.
36. Goldfarb LG. Brown P. Mc Combie WR. Gold-gaber D, Swergold GD, Wills PR. Cervenakova L. Baron II. Gibbs C'J Jr. Gajdusek DC. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octa-pcptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 1991;88:10926-10930.
37. Kitamoto T, Lizuka R, Tateishi J. An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 1993:192:525-531.
38. Medori R, Tritschler H. J, Le Blanc A, Villare F, Manetto V, Chen H. Y, Xuc R, Leal S, Montagna P, Cortclli P. et al: Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992:326: 444-449.
39. Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortclli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P: Fatal familial insomnia and dysau-tonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986:315:997-1003.
40. Pcrani D, Cortclli P, Lucignani G, Montagna P, Tinuper P, Gallassi R, Gambetti P, Lenzi GL, Lugaresi E, Fazio F, I8F-FDG PET in fatal familial insomnia: The functional effects of thalamic lesions. Neurology 1993:43:2565-2569.
41. Manetto V, Medori R. Cortclli P. Montagna P. Tinuper P. Baruzzi A. Rancurel G, Hauw JJ, Vanderhaeghen JJ. Mailleux P. et al: Fatal familial insomnia: Clinical and pathologic study of five new'cases. Neurology 1992:42:312-319.
42. Petersen RB. Tabaton M. Berg L. Schrank B. Torack RM, Leal S. Julicn J. Vital C, Deleplan-quc B. Pcndlebury WW. ct al: Analysis of the prion protein gene in thalamic dementia. Neurology 1992:42:1859-1863.
43. Medori R, Montagna P, Tritschler H. J, LeBlanc A, Cortclli P, Tinuper P, Lugaresi E, Gambetti P: Fatal familial insomnia: A second kindred with mutation of prion protein gene at codon 178. Neurology 1992:42:669-670.
44. Brown P. Goldfarb LG. Kovancn J, Haltia M. Cathala F. Sulima M, Gibbs C'J Jr. Gajdusek DC: Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon l78Asn PRNP mutation. Ann Neurol 1992:31:282-285.
45. Goldfarb LG. Petersen RB. Tabaton M, Brown P. LeBlanc AC, Montagna P. Cortclli P. Julicn J. Vital C. Pendclbury WW. et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992:258:806-808.
46. Palmer MS. Drydcn AJ. Hughes JT. Collinge J: Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991:352:340-342.
47. Collinge J. Palmer MS. Dryden AJ: Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991;337:1441-1442.
48. Gambetti P. Petersen R. Monari I., Tabaton M, AutilioGambetti L. Cortclli P. Montagna P. Lu-garcsi E: Fatal familial insomnia and the widening spectrum of prion diseases. Br Med Bull 1993:49:980-994.
49. Prusiner SB. Scott M. Foster D. Pan KM. Groth D. Mirenda C. Torchia M. Yang SL, Serban D. Carlson GA, ct al: Transgenetic studies implicate interactions between homologous PrP iso-forms in scrapie prion replication. Cell 1990; 63:673-686.
50. Biieler HR, Aguzzi A, Sailer A, Greiner R. A, Autcnried P, Aguet M, Weissmann C: Mice devoid of PrP are resistant to scrapie. Cell 1993: 73:1339-1347.
51. Tateishi J. Kitamoto T: Inherited prion diseases and transmission to rodents. Brain Pathol 1995: 5:53-59.
52. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, De Armond SJ, Prusiner SB: Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995;83:79-90.
53. Hsiao KK. Scott M. Foster D, Groth DF, DeArmond SJ. Prusiner SB: Spontaneous neurode-generation in transgenic mice with mutant prion protein. Science 1990:250:1587-1590.
54. Biieler HR, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C: Normal development and behaviour of mice lacking the neuronal cell-surfacc PrP protein. Nature 1992:356:577-582.
55. Weissmann C. Biieler H. Sailer A. Fischer M. Ague; M. Aguzzi A: Role of PrP in prion diseases. Br Med Bull 1993:49:995-1011.
56. Sailer A. Biieler H. Fischer M. Aguzzi A. Weissmann C: No propagation of prions in mice devoid of PrP. Cell 1994;77:967-968.
57. 1 levels but delayed onset of disease in scrapie inoculated mice heterozygous for a disrupted PrP gene. Mol Med 1994;11:19-30.
58. Collinge J. Palmer MS. Sidle KCL, Hill AF. Gowland L, Meads J, Asante E, Bradley R, Doey L J, Lantos PL: Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 1995:378:779-783.
59. Brandner S, Iscnmann S. Racber A. et al: Normal host prion protein required for scrapie neurotoxicity. Nature 1996:379:339-343.
60. Manson JC. Clarke AR. Hooper ML, Aitchison L. Mc Connell I, Hope J: 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 1994;8:121-127.
61. Jeffrey M. Goodsir CM. Bruce M. Mc Bride PA. Scott JR. Halliday WG: Correlative light and electron microscopy studies of PrP localisation in 87V scrapie. Brain Res 1994:656:329-343.
62. Forloni G. Angeretti N, Chiesa R. Monzani E. Salmona M. Bugiani O, Tagliavini F: Neurotoxicity of a prion protein fragment. Nature 1993: 362:543-546.
63. Muller WE, Ushijima H, Schroder HC. Forrest JM. Schatton WF. Rytik PG. Heffner Lauc M: Cytoprotectivc effect of NMDA receptor antagonists on prion protein PrionScJ-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 1993;246:261-267.
64. Collinge J, Owen F. Poultcr M. Leach M. Crow TJ, Rossor MN, Hardy J. Mullan MJ, Janota I, Lantos PL: Prion dementia without characteristic pathology. Lancet 1990:336:7-9.
65. Hayward PA, Bell JE, Ironside JW: Prion protein immunocytochcmistry: Reliable protocols for the investigation of Creutzfcldt-Jakob disease. Neuropathol Appl Neurobiol 1994;20: 375-383.
66. Shyng SL. Huber MT. Harris DA: A prion protein cycles between the cell surface and an cn-docylic compartment in cultured neuroblastoma cells. J Biol Chem 1993:268:15922-15928.
67. Manson JC. Clarke AR. Mc Bride PA, Mc Connell I, Hope J: PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 1994:3:331-340.